NTLA - Intellia Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NTLA is currently covered by 23 analysts with an average price target of $47.97. This is a potential upside of $34.85 (265.63%) from yesterday's end of day stock price of $13.12.

Intellia Therapeutics's activity chart (see below) currently has 157 price targets and 171 ratings on display. The stock rating distribution of NTLA is 71.43% BUY, 26.98% HOLD and 1.59% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.3% with an average time for these price targets to be met of 112.03 days.

Highest price target for NTLA is $73, Lowest price target is $19, average price target is $47.97.

Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 11-Nov-2024.

Currently out of the existing stock ratings of NTLA, 45 are a BUY (71.43%), 17 are a HOLD (26.98%), 1 are a SELL (1.59%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$60

$46.03 (329.49%)

$70

9 days ago
(11-Nov-2024)

2/10 (20%)

$42.52 (243.25%)

53

Buy

$55

$41.03 (293.70%)

$90

12 days ago
(08-Nov-2024)

4/6 (66.67%)

$38.7 (237.42%)

350

Hold

$20

$6.03 (43.16%)

$32

26 days ago
(25-Oct-2024)

4/6 (66.67%)

$4.05 (25.39%)

20

Hold

$19

$5.03 (36.01%)

$29

26 days ago
(25-Oct-2024)

3/6 (50%)

$3.05 (19.12%)

20

Buy

$54

$40.03 (286.54%)

$54

2 months 1 days ago
(19-Sep-2024)

2/6 (33.33%)

$31.07 (135.50%)

32

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NTLA (Intellia Therapeutics) average time for price targets to be met?

On average it took 112.03 days on average for the stock forecasts to be realized with a an average price target met ratio 41.3

Which analyst has the current highest performing score on NTLA (Intellia Therapeutics) with a proven track record?

GEULAH LIVSHITS

Which analyst has the most public recommendations on NTLA (Intellia Therapeutics)?

Geulah Livshits works at CHARDAN CAPITAL and has 9 price targets and 12 ratings on NTLA

Which analyst is the currently most bullish on NTLA (Intellia Therapeutics)?

Swapnil Malekar with highest potential upside - $149.03

Which analyst is the currently most reserved on NTLA (Intellia Therapeutics)?

Martin Auster with lowest potential downside - -$7.62

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?